Sarepta Rebounded. Its Gene Therapy Is Back on Course.
The future of Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy looked grim two months ago. There’s been a 180 since.
Source: marketwatch.com
Josephp Schwartz News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Josephp Schwartz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Josephp Schwartz Today - Breaking & Trending Today
Pfizer to Acquire Arena for $6.7B, Expanding Immuno-Inflammatory Pipeline
Pfizer has agreed to acquire Arena Pharmaceuticals for approximately $6.7 billion, in a deal designed to expand the buyer’s immuno-inflammatory disease pipeline, led by Arena’s Phase II/II lead candidate etrasimod.
Source: genengnews.com
ChemoCentryx Inc (CCXI) Q1 2021 Earnings Call Transcript
ChemoCentryx Inc (CCXI) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. ChemoCentryx Inc (NASDAQ: CCXI) Operator Good day and thank you for standing by. Welcome to the ChemoCentryx First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the c...
Source: msn.com